- Home
- MITQ vs POAI Comparison
MITQ vs POAI Comparison
Compare MITQ & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITQ
- POAI
- Stock Information
- Founded
- MITQ N/A
- POAI 2002
- Country
- MITQ United States
- POAI United States
- Employees
- MITQ N/A
- POAI N/A
- Industry
- MITQ Telecommunications Equipment
- POAI Industrial Specialties
- Sector
- MITQ Telecommunications
- POAI Health Care
- Exchange
- MITQ Nasdaq
- POAI Nasdaq
- Market Cap
- MITQ 6.0M
- POAI 4.9M
- IPO Year
- MITQ 2021
- POAI N/A
- Fundamental
- Price
- MITQ $0.63
- POAI $0.72
- Analyst Decision
- MITQ
- POAI Hold
- Analyst Count
- MITQ 0
- POAI 1
- Target Price
- MITQ N/A
- POAI N/A
- AVG Volume (30 Days)
- MITQ 23.9K
- POAI 91.7K
- Earning Date
- MITQ 11-14-2024
- POAI 11-12-2024
- Dividend Yield
- MITQ N/A
- POAI N/A
- EPS Growth
- MITQ N/A
- POAI N/A
- EPS
- MITQ N/A
- POAI N/A
- Revenue
- MITQ $18,756,000.00
- POAI $1,484,223.00
- Revenue This Year
- MITQ N/A
- POAI N/A
- Revenue Next Year
- MITQ N/A
- POAI $502.91
- P/E Ratio
- MITQ N/A
- POAI N/A
- Revenue Growth
- MITQ N/A
- POAI N/A
- 52 Week Low
- MITQ $0.42
- POAI $0.55
- 52 Week High
- MITQ $1.44
- POAI $3.76
- Technical
- Relative Strength Index (RSI)
- MITQ 53.31
- POAI 49.72
- Support Level
- MITQ $0.60
- POAI $0.62
- Resistance Level
- MITQ $0.67
- POAI $0.89
- Average True Range (ATR)
- MITQ 0.05
- POAI 0.10
- MACD
- MITQ 0.00
- POAI -0.01
- Stochastic Oscillator
- MITQ 56.32
- POAI 38.18
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.